These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
303 related articles for article (PubMed ID: 31332647)
1. Human bone marrow-derived mesenchymal stem cell-secreted exosomes overexpressing microRNA-34a ameliorate glioblastoma development via down-regulating MYCN. Wang B; Wu ZH; Lou PY; Chai C; Han SY; Ning JF; Li M Cell Oncol (Dordr); 2019 Dec; 42(6):783-799. PubMed ID: 31332647 [TBL] [Abstract][Full Text] [Related]
2. microRNA-16-5p-containing exosomes derived from bone marrow-derived mesenchymal stem cells inhibit proliferation, migration, and invasion, while promoting apoptosis of colorectal cancer cells by downregulating ITGA2. Xu Y; Shen L; Li F; Yang J; Wan X; Ouyang M J Cell Physiol; 2019 Nov; 234(11):21380-21394. PubMed ID: 31102273 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-128-3p Enhances the Chemosensitivity of Temozolomide in Glioblastoma by Targeting c-Met and EMT. Zhao C; Guo R; Guan F; Ma S; Li M; Wu J; Liu X; Li H; Yang B Sci Rep; 2020 Jun; 10(1):9471. PubMed ID: 32528036 [TBL] [Abstract][Full Text] [Related]
4. Exosomes derived from microRNA-199a-overexpressing mesenchymal stem cells inhibit glioma progression by down-regulating AGAP2. Yu L; Gui S; Liu Y; Qiu X; Zhang G; Zhang X; Pan J; Fan J; Qi S; Qiu B Aging (Albany NY); 2019 Aug; 11(15):5300-5318. PubMed ID: 31386624 [TBL] [Abstract][Full Text] [Related]
5. Human bone marrow mesenchymal stem cells-derived microRNA-205-containing exosomes impede the progression of prostate cancer through suppression of RHPN2. Jiang S; Mo C; Guo S; Zhuang J; Huang B; Mao X J Exp Clin Cancer Res; 2019 Dec; 38(1):495. PubMed ID: 31847864 [TBL] [Abstract][Full Text] [Related]
6. Exosomal transfer of miR-151a enhances chemosensitivity to temozolomide in drug-resistant glioblastoma. Zeng A; Wei Z; Yan W; Yin J; Huang X; Zhou X; Li R; Shen F; Wu W; Wang X; You Y Cancer Lett; 2018 Nov; 436():10-21. PubMed ID: 30102952 [TBL] [Abstract][Full Text] [Related]
7. RUNX1 (RUNX family transcription factor 1), a target of microRNA miR-128-3p, promotes temozolomide resistance in glioblastoma multiform by upregulating multidrug resistance-associated protein 1 (MRP1). Xu J; Song J; Xiao M; Wang C; Zhang Q; Yuan X; Tian S Bioengineered; 2021 Dec; 12(2):11768-11781. PubMed ID: 34895074 [TBL] [Abstract][Full Text] [Related]
8. Human bone marrow-derived mesenchymal stem overexpressing microRNA-124-3p inhibit DLBCL progression by downregulating the NFATc1/cMYC pathway. Zhao X; Xu M; Hu X; Ding X; Zhang X; Xu L; Li L; Sun X; Song J Stem Cell Res Ther; 2023 May; 14(1):148. PubMed ID: 37248542 [TBL] [Abstract][Full Text] [Related]
9. Exosomal transfer of miR-1238 contributes to temozolomide-resistance in glioblastoma. Yin J; Zeng A; Zhang Z; Shi Z; Yan W; You Y EBioMedicine; 2019 Apr; 42():238-251. PubMed ID: 30917935 [TBL] [Abstract][Full Text] [Related]
10. Extracellular vesicles carry miR-27a-3p to promote drug resistance of glioblastoma to temozolomide by targeting BTG2. Chen L; Li Z; Hu S; Deng Q; Hao P; Guo S Cancer Chemother Pharmacol; 2022 Feb; 89(2):217-229. PubMed ID: 35039898 [TBL] [Abstract][Full Text] [Related]
12. Delivery of Exogenous miR-124 to Glioblastoma Multiform Cells by Wharton's Jelly Mesenchymal Stem Cells Decreases Cell Proliferation and Migration, and Confers Chemosensitivity. Sharif S; Ghahremani MH; Soleimani M Stem Cell Rev Rep; 2018 Apr; 14(2):236-246. PubMed ID: 29185191 [TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stem cell-derived exosomal microRNA-133b suppresses glioma progression via Wnt/β-catenin signaling pathway by targeting EZH2. Xu H; Zhao G; Zhang Y; Jiang H; Wang W; Zhao D; Hong J; Yu H; Qi L Stem Cell Res Ther; 2019 Dec; 10(1):381. PubMed ID: 31842978 [TBL] [Abstract][Full Text] [Related]
14. Human marrow stromal cells secrete microRNA-375-containing exosomes to regulate glioma progression. Deng SZ; Lai MF; Li YP; Xu CH; Zhang HR; Kuang JG Cancer Gene Ther; 2020 Apr; 27(3-4):203-215. PubMed ID: 30728448 [TBL] [Abstract][Full Text] [Related]
15. Exosomal transfer of miR‑25‑3p promotes the proliferation and temozolomide resistance of glioblastoma cells by targeting FBXW7. Wang J; Li T; Wang B Int J Oncol; 2021 Aug; 59(2):. PubMed ID: 34278448 [TBL] [Abstract][Full Text] [Related]
16. CRISPR-Cas9 library screening combined with an exosome-targeted delivery system addresses tumorigenesis/TMZ resistance in the mesenchymal subtype of glioblastoma. Zhao J; Cui X; Zhan Q; Zhang K; Su D; Yang S; Hong B; Wang Q; Ju J; Cheng C; Li C; Wan C; Wang Y; Zhou J; Kang C Theranostics; 2024; 14(7):2835-2855. PubMed ID: 38773970 [No Abstract] [Full Text] [Related]
17. Exosomes from human-bone-marrow-derived mesenchymal stem cells protect against renal ischemia/reperfusion injury via transferring miR-199a-3p. Zhu G; Pei L; Lin F; Yin H; Li X; He W; Liu N; Gou X J Cell Physiol; 2019 Dec; 234(12):23736-23749. PubMed ID: 31180587 [TBL] [Abstract][Full Text] [Related]
18. Inhibiting microRNA-424 in bone marrow mesenchymal stem cells-derived exosomes suppresses tumor growth in colorectal cancer by upregulating TGFBR3. Zhang N; Li L; Luo J; Tan J; Hu W; Li Z; Wang X; Ye T Arch Biochem Biophys; 2021 Sep; 709():108965. PubMed ID: 34129838 [TBL] [Abstract][Full Text] [Related]
19. Exosomes derived from microRNA-512-5p-transfected bone mesenchymal stem cells inhibit glioblastoma progression by targeting JAG1. Yan T; Wu M; Lv S; Hu Q; Xu W; Zeng A; Huang K; Zhu X Aging (Albany NY); 2021 Mar; 13(7):9911-9926. PubMed ID: 33795521 [TBL] [Abstract][Full Text] [Related]